Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

denk pharma gmbh & co. kg prinzregentenstrasse 79 81675 mÜnchen (duitsland) - vildagliptine 50 mg/stuk - tablet - cellulose, microkristallijn (e 460(i)) ; lactose 0-water ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd, cellulose, microkristallijn (e 460) ; lactose 0-water ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd - vildagliptin

Europese Unie - Nederlands - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

hetero europe s.l. viladecans business park, edificio brasil, catalunya 83-85 08840 viladecans (spanje) - vildagliptine 50 mg/stuk - tablet - cellulose, microkristallijn (e 460(i)) ; lactose 0-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat, cellulose, microkristallijn (e 460) ; lactose 0-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat

Europese Unie - Nederlands - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

vildagliptine 50 mg/stuk - tablet - cellulose, microkristallijn (e 460(i)) ; lactose 0-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat, cellulose, microkristallijn (e 460) ; lactose 0-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

metforminehydrochloride 1000 mg/stuk samenstelling overeenkomend met ; metformine 780 mg/stuk ; vildagliptine 50 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; hydroxypropylcellulose, laag gesubstitueerd (e 463a) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hydroxypropylcellulose, laag gesubstitueerd (e 463) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; talk (e 553 b) ; titaandioxide (e 171)

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

metforminehydrochloride 850 mg/stuk samenstelling overeenkomend met ; metformine 660 mg/stuk ; vildagliptine 50 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; hydroxypropylcellulose, laag gesubstitueerd (e 463a) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hydroxypropylcellulose, laag gesubstitueerd (e 463) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; talk (e 553 b) ; titaandioxide (e 171)

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - metforminehydrochloride samenstelling overeenkomend met ; metformine ; vildagliptine - filmomhulde tablet - hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 4000 ; magnesiumstearaat (e 470b) ; talk (e 553 b) ; titaandioxide (e 171), - metformin and vildagliptin

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - metforminehydrochloride samenstelling overeenkomend met ; metformine ; vildagliptine - filmomhulde tablet - hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 4000 ; magnesiumstearaat (e 470b) ; talk (e 553 b) ; titaandioxide (e 171), - metformin and vildagliptin

Europese Unie - Nederlands - EMA (European Medicines Agency)

novartis europharm limited - vildagliptine - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).